NASDAQ:YMAB

Y-mAbs Therapeutics (YMAB) Earnings Date, Estimates & Call Transcripts

$8.70

-0.30 (-3.33%)

(As of 05/26/2023 ET)

Compare

Today's Range: $8.64
▼
$9.23
50-Day Range: $2.83
▼
$10.34
52-Week Range: $2.70
▼
$20.48

Volume: 244,566 shs
Average Volume: 446,373 shs
Market Capitalization: $380.02 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.67

Upcoming Earnings Date: Aug. 14Estimated
Actual EPS (May. 8): -$0.15 Beat By $0.16
Consensus EPS (May. 8): -$0.31
Last Year's Q2 EPS (5/9/2022): -$0.64

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

YMAB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

YMAB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Y-mAbs Therapeutics Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	2	($0.34)	($0.32)	($0.33)
Q2 2023	2	($0.29)	($0.23)	($0.26)
Q3 2023	2	($0.29)	($0.24)	($0.27)
Q4 2023	2	($0.29)	($0.22)	($0.26)
FY 2023	8	($1.21)	($1.01)	($1.11)
Q1 2024	1	($0.22)	($0.22)	($0.22)
Q2 2024	1	($0.19)	($0.19)	($0.19)
Q3 2024	1	($0.18)	($0.18)	($0.18)

YMAB Earnings Date and Information

Y-mAbs Therapeutics last posted its earnings data on May 8th, 2023. The reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.16. The business had revenue of $20.30 million for the quarter, compared to the consensus estimate of $15.55 million. Its revenue for the quarter was up 93.3% on a year-over-year basis. Y-mAbs Therapeutics has generated ($1.69) earnings per share over the last year (($1.69) diluted earnings per share). Earnings for Y-mAbs Therapeutics are expected to grow in the coming year, from ($0.96) to ($0.66) per share. Y-mAbs Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off prior year's report dates.

Y-mAbs Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/14/2023 (Estimated)
5/8/2023	Q1 2023	($0.31)	($0.15)	+$0.16	($0.15)	$15.55 million	$20.30 million
3/31/2023	Q4 2022	($0.44)	$0.03	+$0.47	$0.03	$20.35 million	$31.45 million
11/7/2022	Q3 2022	($0.75)	($0.63)	+$0.12	($0.63)	$11.69 million	$12.54 million
8/8/2022	Q2 2022	($0.68)	($0.94)	($0.26)	($0.94)	$11.22 million	$10.80 million
5/9/2022	Q1 2022	($0.71)	($0.64)	+$0.07	($0.64)	$11.10 million	$10.49 million
2/24/2022	Q4 2021	($0.71)	($0.85)	($0.14)	($0.85)	$10.82 million	$9.60 million
11/4/2021	9/30/2021	($0.58)	($0.66)	($0.08)	($0.66)	$10.87 million	$8.97 million
8/5/2021	6/30/2021	($0.68)	($0.53)	+$0.15	($0.53)	$7.66 million	$10.95 million
5/6/2021	3/31/2021	$0.61	$0.75	+$0.14	$0.75	$35.67 million	$5.38 million
2/25/2021	Q4 2020	($0.85)	($0.49)	+$0.36	($0.49)	$4.18 million	$20.75 million
11/12/2020	9/30/2020	($0.80)	($0.82)	($0.02)	($0.82)
8/6/2020	Q2 2020	($0.69)	($1.01)	($0.32)	($1.01)
5/7/2020	3/31/2020	($0.62)	($0.66)	($0.04)	($0.66)
3/12/2020	12/31/2019	($0.67)	($0.60)	+$0.07	($0.60)
11/13/2019	Q3	($0.54)	($0.70)	($0.16)	($0.70)
8/14/2019	Q2 2019	($0.48)	($0.53)	($0.05)	($0.53)
5/10/2019	Q1 2019	($0.40)	($0.47)	($0.07)	($0.47)
3/22/2019	Q4	($0.31)	($0.42)	($0.11)	($0.42)
11/13/2018	Q3 2018	($0.33)	($0.42)	($0.09)	($0.42)

Y-mAbs Therapeutics Earnings - Frequently Asked Questions

When is Y-mAbs Therapeutics's earnings date?: Y-mAbs Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off last year's report dates. Learn more on YMAB's earnings history.
Did Y-mAbs Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Y-mAbs Therapeutics (NASDAQ:YMAB) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.16. Learn more on analysts' earnings estimate vs. YMAB's actual earnings.
How can I listen to Y-mAbs Therapeutics's earnings conference call?: The conference call for Y-mAbs Therapeutics's latest earnings report can be listened to online. Listen to Conference Call
How can I read Y-mAbs Therapeutics's conference call transcript?: The conference call transcript for Y-mAbs Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Y-mAbs Therapeutics generate each year?: Y-mAbs Therapeutics (NASDAQ:YMAB) has a recorded annual revenue of $65.27 million.
How much profit does Y-mAbs Therapeutics generate each year?: Y-mAbs Therapeutics (NASDAQ:YMAB) has a recorded net income of -$95.57 million. YMAB has generated -$1.69 earnings per share over the last four quarters.
What is Y-mAbs Therapeutics's EPS forecast for next year?: Y-mAbs Therapeutics's earnings are expected to grow from ($0.96) per share to ($0.66) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:YMAB) was last updated on 5/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Y-mAbs Therapeutics (YMAB) Earnings Date, Estimates & Call Transcripts

YMAB Earnings Estimates and Actuals by Quarter

YMAB Estimated and Actual Revenue by Quarter

Y-mAbs Therapeutics Analyst Forecasts

YMAB Earnings Date and Information

Y-mAbs Therapeutics Earnings History by Quarter

Y-mAbs Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Y-mAbs Therapeutics (YMAB) Earnings Date, Estimates & Call Transcripts

Earnings Summary

YMAB Earnings Estimates and Actuals by Quarter

YMAB Estimated and Actual Revenue by Quarter

Y-mAbs Therapeutics Analyst Forecasts

YMAB Earnings Date and Information

Y-mAbs Therapeutics Earnings History by Quarter

Y-mAbs Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat